Protara Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 57.38% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
23.6%	Opaleye Management Inc.	2,692,594	US$8.1m	0%	1.81%
7.32%	Jesse Shefferman	836,764	US$2.5m	2.99%	no data
5.25%	Heights Capital Management, Inc.	600,380	US$1.8m	0%	0.93%
5.12%	Randall Marshall	585,600	US$1.8m	0%	no data
3.74%	The Vanguard Group, Inc.	427,612	US$1.3m	0%	no data
1.83%	Tavistock Life Sciences	209,227	US$627.7k	0%	0.03%
1.75%	Baker Bros. Advisors LP	199,671	US$599.0k	0%	0.01%
1.65%	Ikarian Capital, LLC	188,664	US$566.0k	0%	0.13%
1.05%	Privium Fund Management (UK) Limited	119,730	US$359.2k	0%	0.22%
0.99%	Renaissance Technologies LLC	113,300	US$339.9k	88.5%	no data
0.69%	Geode Capital Management, LLC	78,518	US$235.6k	0%	no data
0.56%	Bridgeway Capital Management, LLC	64,000	US$192.0k	0%	no data
0.55%	Jacqueline Zummo	63,329	US$190.0k	24.7%	no data
0.55%	Medical Strategy GmbH, Asset Management Arm	63,282	US$189.8k	0%	0.01%
0.33%	Citadel Advisors LLC	38,035	US$114.1k	71.8%	no data
0.3%	BlackRock, Inc.	34,316	US$102.9k	-0.83%	no data
0.27%	Gregory Sargen	31,000	US$93.0k	0%	no data
0.27%	Richard Levy	31,000	US$93.0k	0%	no data
0.27%	State Street Global Advisors, Inc.	30,900	US$92.7k	0%	no data
0.26%	Luke Beshar	30,000	US$90.0k	0%	no data
0.24%	Two Sigma Advisers, LP	27,018	US$81.1k	-2.88%	no data
0.23%	Michael Solomon	26,500	US$79.5k	0%	no data
0.22%	Abaris Investment Management AG	25,500	US$76.5k	0%	0.13%
0.22%	Two Sigma Investments, LP	25,145	US$75.4k	-8.05%	no data
0.16%	Boothbay Fund Management, LLC	18,864	US$56.6k	0%	no data